These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2138420)

  • 21. Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats.
    Flanagan ET; Buckley MM; Aherne CM; Lainis F; Sattar M; Johns EJ
    Exp Physiol; 2008 Sep; 93(9):1058-64. PubMed ID: 18487313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased protein synthesis and degradation in the dog heart during thyroxine administration.
    Bonnin CM; Sparrow MP; Taylor RR
    J Mol Cell Cardiol; 1983 Apr; 15(4):245-50. PubMed ID: 6224024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol.
    Klein I
    Endocrinology; 1988 Jul; 123(1):203-10. PubMed ID: 2968237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of protein synthesis in cell-free system prepared from hypertrophied rat heart during L-triiodothyronine treatment.
    Bachner L; Raymondjean M; Bogdanovsky D; Kneip B; Schapira G
    Biochimie; 1977; 59(11-12):863-8. PubMed ID: 147109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of thyrotoxicosis and recovery on myocardial protein balance.
    Wildenthal K; Sanford CF; Griffin EE; Crie JS
    Adv Myocardiol; 1980; 1():503-7. PubMed ID: 6446743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional changes in ornithine decarboxylase activity and polyamine levels during thyroxine-induced cardiac hypertrophy.
    Tipnis UR; Skiera C
    Cytobios; 1989; 57(229):101-8. PubMed ID: 2528442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroxine influences on contractile proteins from atrial and ventricular myocardium.
    Syrový I
    Physiol Bohemoslov; 1986; 35(6):491-6. PubMed ID: 2950533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone responses to thyroid hormone in the neonatal rat: resistance and anamnestic response.
    Seo H; Wunderlich C; Vassart G; Refetoff S
    J Clin Invest; 1981 Feb; 67(2):569-74. PubMed ID: 7462429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart.
    Klein I; Hong C
    J Clin Invest; 1986 May; 77(5):1694-8. PubMed ID: 2939104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a cytosolic triiodothyronine binding protein in atrium and ventricle of rat heart with different sensitivity toward thyroid hormone levels.
    Osty J; Rappaport L; Samuel JL; Lennon AM
    Endocrinology; 1988 Mar; 122(3):1027-33. PubMed ID: 3342743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordinated capillary and myocardial growth in response to thyroxine treatment.
    Tomanek RJ; Busch TL
    Anat Rec; 1998 May; 251(1):44-9. PubMed ID: 9605219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propranolol and bepridil attenuating levothyroxine-induced rat cardiac hypertrophy and mitochondrial Ca2+ Mg(2+)-ATPase activity elevation.
    Chen DD; Dai DZ; Lu J; Zhang XK
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):516-8. PubMed ID: 9863145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial characteristics of thyroxine stimulated hypertrophy. A structural and functional study.
    Breisch EA; White FC; Hammond HK; Flynn S; Bloor CM
    Basic Res Cardiol; 1989; 84(4):345-58. PubMed ID: 2530972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coupling of mitochondrial metabolism and protein synthesis in heart mitochondria.
    McKee EE; Grier BL; Thompson GS; Leung AC; McCourt JD
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E503-10. PubMed ID: 2316644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration.
    Dong F; Zhang X; Culver B; Chew HG; Kelley RO; Ren J
    Clin Sci (Lond); 2005 Sep; 109(3):277-86. PubMed ID: 15877545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triiodothyronine decreases the accumulation of 1,2-diacylglycerol in rat hearts.
    Okumura K; Matsui H; Kikuchi M; Mukawa H; Toki Y; Ito T
    Can J Cardiol; 1995; 11(7):565-72. PubMed ID: 7544686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid hormone regulates expression of shaker-related potassium channel mRNA in rat heart.
    Abe A; Yamamoto T; Isome M; Ma M; Yaoita E; Kawasaki K; Kihara I; Aizawa Y
    Biochem Biophys Res Commun; 1998 Apr; 245(1):226-30. PubMed ID: 9535813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicology and carcinogenesis studies of 3,3',4,4'-tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan Sprague-Dawley rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Nov; (558):1-206. PubMed ID: 21383777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.